Product containing precisely naloxone hydrochloride 5 milligram and oxycodone hydrochloride 10 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 14985811000001101 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
776864003Oxycodone + Naloxone
product
10363801000001108Virtual medicinal product
product
38419711000001105Myloxifin 10mg/5mg modified-release tablets (Ridge Pharma Ltd)
real clinical drug
38801811000001106Oxyargin 10mg/5mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
42757611000001101Sofonac 10mg/5mg modified-release tablets (G.L. Pharma UK Ltd)
real clinical drug
37390111000001103Targinact 10mg/5mg modified-release tablets (CST Pharma Ltd)
real clinical drug
38168711000001101Targinact 10mg/5mg modified-release tablets (DE Pharmaceuticals)
real clinical drug
14975711000001101Targinact 10mg/5mg modified-release tablets (Napp Pharmaceuticals Ltd)
real clinical drug
43397511000001101Targinact 10mg/5mg modified-release tablets (Necessity Supplies Ltd)
real clinical drug
37704311000001105Targinact 10mg/5mg modified-release tablets (Pilsco Ltd)
real clinical drug
21503511000001104Targinact 10mg/5mg modified-release tablets (Waymade Healthcare Plc)
real clinical drug